NEA Diagnostics
Certificate of analysis
2026-AAAABBAA9
NAD+ - 500mg
Tested for: Lumen Health
Reported 23 Jun 2026
PASS
Purity
96%
Label claim
500 mg
Measured
441 mg
Of label
88.2%
COA #
2026-AAAABBAA9
Accession
AAAABBAA9
Labeled content
500 mg
Purity
96%
Net peptide content
441 mg
Appearance
White Lyophilized Powder
Reported date
23 Jun 2026
Mass identificationPurityNet peptide content
NAD+96%441 mg
Identity confirmation
Status
✓ Confirmed
Expected mass
663.4 Da
Observed mass
663.4 Da
HPLC chromatogram
Reverse phase HPLC with UV at 260 nm
PeakRT (min)Area %
Solvent front1.21
NAD main peak3.4496
Degradation product3.912.8
Heavy Metal Analysis (ICP-MS)
TestSpecificationResultsStatus
Arsenic (As)NMT 1.0 ppmNot detectedPASS
Cadmium (Cd)NMT 1.0 ppmNot detectedPASS
Chromium (Cr)NMT 5 ppmNot detectedPASS
Mercury (Hg)NMT 1.5 ppmNot detectedPASS
Lead (Pb)NMT 0.5 ppmNot detectedPASS
Sterility Testing (PCR)
TestSpecificationResultsStatus
Sterility (PCR)No GrowthNo GrowthPASS
Endotoxin Testing (USP <85>)
TestSpecificationResultsStatus
Endotoxin (USP <85>)Report ResultNMT 0.05 EU/mLReported
About this result: contamination is reported as a quantitative value. Acceptable limits vary by product type and dose route; no unversioned threshold applies to RUO products. This result is below commonly referenced endotoxin thresholds.
Instrument: Agilent 1260 Infinity II
Laboratory: NEA Diagnostics, San Diego, CA
This page is the authoritative version of certificate 2026-AAAABBAA9. Any PDF copy should match it exactly. For research use only.
Searchable via labneadiagnostics.comCOA # 2026-AAAABBAA9 · Issued 23 Jun 2026